| --- | --- | --- | --- | |-----------------------------------------|----------------------------------------------------------------------|-------|--------------------------------------------| | | | | | | | | | | | | Commission file number: | | 001-13221 | | (Exact | Cullen/Frost Bankers, Inc. name of registrant as specified | | in its charter) | | Texas | | | 74-1751768 | | (State or other jurisdiction of | incorporation or organization) | | (I.R.S. Employer Identification No.) | | 111 W. Houston Street, ...

Cullen/Frost Bankers (CFR) reported $522.74 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 1.6%. EPS of $2.15 for the same period compares to $2.70 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $524.89 million, representing a surprise of -0.41%. The company delivered an EPS surprise of +0.94%, with the consensus EPS estimate being $2.13.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...

Cullen/Frost Bankers (CFR) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $2.70 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.94%. A quarter ago, it was expected that this financial holding company would post earnings of $2.01 per share when it actually produced earnings of $2.18, delivering a surprise of 8.46%.Over the last four qu ...

| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|------------------------------------| | | | | | | A.B. Mendez Investor Relations | | | | | | | 210.220.5234 | | | | | | | or | | | | | | | Bill Day | | | | | | | Media Relations | | | | | | | 210.220.5427 | | --- | |------------------------------------------------------------------------------------------------------------------------------------------------| | | | Net income available to common shareholders for the first quarter ...

Wall Street analysts forecast that Cullen/Frost Bankers (CFR) will report quarterly earnings of $2.13 per share in its upcoming release, pointing to a year-over-year decline of 21.1%. It is anticipated that revenues will amount to $524.93 million, exhibiting a decline of 1.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have re ...

Cullen/Frost Bankers, Inc.’s (CFR) strong loan book, solid net interest income (NII) and steady capital distribution activities are positives. Also, efforts to expand its presence in Texas bode well for CFR's long-term growth. However, the company is affected by mounting costs and an undiversified loan portfolio.CFR’s deposits witnessed a five-year compound annual growth rate (CAGR) of 9.1% (2018-2023), while loans, net of unearned discounts, recorded a CAGR of 6%. Moreover, branch openings in 2024 will lik ...

SAN ANTONIO, Feb. 21, 2024 /PRNewswire/ -- Frost Bank, one of the largest banks based in Texas, received 34 Greenwich Excellence and Best Brand Awards – the highest amount received nationwide for the eighth consecutive year – for providing superior service, advice and performance to small-business and middle-market banking clients. As in previous years, Frost is the only Texas-based bank to receive national recognition for "Overall Satisfaction" and "Likelihood to Recommend" in both the middle-market and sm ...

| --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------|--------|--------------------------|-------|------------------------------|-------|---------------|-----------------------------------------------------------------------------| | 2023 | Credit | Loss Expense (Benefit) | | Net (Charge-Offs) Recoveries | | Average Loans | Ratio of Annualized Net (Charge-Offs) Recoveries to Average Loans | | Commercial and industrial | $ | (16,709) | $ | (13,522) | $ | 5,734,509 | (0.24)% | | ...

Dilok Klaisataporn/iStock via Getty Images MoneyShow’s top contributing analysts, strategists, and newsletter editors share their investment recommendations for the year ahead. See Part 2 here. Celldex Therapeutics By John McCamant, Editor of The Medical Technology Stock Letter Celldex Therapeutics (CLDX) is one of our top picks for 2024. The recently reported 208-patient trial with the first-ever subcutaneous (SC) version of CLDX’s barzo in CSU confirmed that it is the Best-In-Class compound with the f ...

SAN ANTONIO, Jan. 26, 2024 /PRNewswire/ -- The board of directors of Cullen/Frost Bankers, Inc. (NYSE: CFR) announced that Hope Andrade has been elected to the board. Andrade will join the board's Audit and Risk committees."We're fortunate to add someone of Hope's experience and prestige to our board of directors," said Phil Green, Cullen/Frost Chairman and CEO. "She is a longtime Texas entrepreneur and leader with a wealth of knowledge about the workings of our state. All of us look forward to having her p ...